Eggleston, A <br/><br/>
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  May 2009 
 - 967-78 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2009.03948.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Ulcer Agents--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Esomeprazole--administration & dosage<br/>Female<br/>Gastroesophageal Reflux--drug therapy<br/>Heartburn--drug therapy<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori<br/>Humans<br/>Male<br/>Middle Aged<br/>Primary Health Care<br/>Rabeprazole<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult